Adma Biologics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Adma Biologics
Tip: Access up to 7 years of quarterly data
All positions including Adma Biologics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adma Biologics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $12M | 589k | 19.99 |
| 2024-06-30 | $8.9M | 792k | 11.18 |
| 2024-03-31 | $2.1M | 325k | 6.60 |
| 2023-12-31 | $1.8M | 395k | 4.52 |
| 2023-09-30 | $2.0M | 557k | 3.58 |
| 2023-06-30 | $3.0M | 825k | 3.69 |
| 2023-03-31 | $2.7M | 818k | 3.31 |
| 2022-12-31 | $3.2M | 815k | 3.88 |
| 2022-09-30 | $403k | 166k | 2.43 |
| 2022-06-30 | $62k | 32k | 1.97 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management